The magnitude of the Costochondritis market is a direct reflection of the global prevalence of non-cardiac chest pain and the necessity for diagnostic measures to rule out life-threatening conditions. The global Costochondritis Market Size was valued at an estimated USD 1.39 Billion in 2023, with projections showing considerable future expansion. The market value is heavily weighted by the diagnostic segment, which includes imaging services (X-rays, ECGs, and sometimes MRI/CT scans) and laboratory tests, as these are mandatory steps in differentiating costochondritis from cardiac events like myocardial infarction. Although the condition itself is often self-limiting, the high volume of emergency department visits where this differential diagnosis is performed contributes significantly to the overall market valuation. Furthermore, the market size is influenced by the sustained demand for over-the-counter and prescription anti-inflammatory medications. The projected growth indicates that factors such as the increasing age of the global population, which correlates with a higher incidence of inflammatory conditions, and increased healthcare utilization will continue to swell the market size over the coming decade.